Current Opinion in Pulmonary Medicine

Papers
(The median citation count of Current Opinion in Pulmonary Medicine is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
The persistent problem of persistent air-leaks: approach to management78
Thoracic empyema: aetiology, diagnosis, treatment, and prevention45
Cardiac sarcoidosis and neurosarcoidosis – multidisciplinary approach for diagnosis35
Home monitoring in asthma: towards digital twins30
Spirometry, computed tomography, comorbidities, oxygen therapy and other topics in chronic obstructive pulmonary disease and an update on silicosis28
Bronchoscopic treatment of early-stage peripheral lung cancer27
The role of PET in the management of sarcoidosis26
Digital outcome measures in pulmonary clinical trials21
Lung microbiome, gut–lung axis and chronic obstructive pulmonary disease21
The evolving role of radiological imaging in cystic fibrosis21
Improving care in lung cancer surgery: a review of quality measures and evolving standards20
Evolving nutritional needs, obesity, and overweight status in cystic fibrosis19
Group 2 pulmonary hypertension: from diagnosis to treatment18
Genetic background of pulmonary (vascular) diseases – how much is written in the codes?18
Novel interventions on the tricuspid valve: how to consider the pulmonary circulation?17
Disease-specific gaps within fungal respiratory tract infections: clinical features, diagnosis, and management in critically ill patients17
Micro-RNA in obstructive sleep apnoea: biomarker of cardiovascular outcome?16
The role of chest computed tomography in the evaluation and management of chronic obstructive pulmonary disease15
Implementation of digital home monitoring and management of respiratory disease15
Bronchoscopic diagnosis of peripheral lung lesions15
Lung transplant referral considerations for individuals with cystic fibrosis14
Considerations and clinical management of infections in sarcoidosis14
Editorial introductions14
Elexacaftor–tezacaftor–ivacaftor use after solid organ transplant14
Asthma in pregnancy: a review of recent literature14
The future of clinical trials in idiopathic pulmonary fibrosis13
Editorial introductions13
Paediatric asthma - all that wheezes is not necessarily asthma - current diagnostic and management strategies13
Sarcoidosis and frailty: recognizing factors that foster holistic resilience12
Mechanisms relating to sleeping position to the endotypes of sleep disordered breathing12
Food for thought: optimal diet in patients with asthma and chronic obstructive pulmonary disease12
The modern landscape of fertility, pregnancy, and parenthood in people with cystic fibrosis12
Co-morbid insomnia and sleep apnea (COMISA): recent research and future directions12
Cystic fibrosis liver disease in the post-modulator era12
Casting light on the many facets of sarcoidosis12
Progress for all: addressing disparities in sarcoidosis12
Household air pollution and respiratory health in Africa: persistent risk and unchanged health burdens12
An update of palliative care in lung transplantation with a focus on symptoms, quality of life and functional outcomes12
Management of patients with idiopathic pulmonary fibrosis and lung cancer: challenges in clinical practice12
Acute rejection post lung transplant11
Chronic obstructive pulmonary disease risk assessment tools: is one better than the others?11
Tobacco treatment in the setting of lung cancer screening11
Digital inhalers for asthma management11
Patterns of progression in non-IPF fibrotic interstitial lung disease10
Home monitoring of coronavirus disease 2019 patients in different phases of disease10
Imaging in peripheral bronchoscopy10
Therapeutic pipeline for individuals with cystic fibrosis with mutations nonresponsive to current cystic fibrosis transmembrane conductance regulator modulators10
Utility of peak inspiratory flow measurement for dry powder inhaler use in chronic obstructive pulmonary disease10
Effectiveness and safety of coronavirus disease 2019 vaccines10
What causes cough in pulmonary fibrosis, and how should we treat it?10
Editorial: Silicosis, asbestos-related diseases, war-site exposures and a variety of topics in chronic obstructive pulmonary disease9
Novel insights in fibrotic pulmonary sarcoidosis9
Chronic daily respiratory care needs in people with cystic fibrosis treated with highly effective cystic fibrosis transmembrane conductance regulator modulators9
Mass gathering events and transmission of respiratory tract infections: updates pre and post COVID-19 lockdown9
Editorial: Are we ready for prime time?9
Neuropsychiatric adverse effects from CFTR modulators deserve a serious research effort9
Obstructive lung diseases burden and COVID-19 in developing countries: a perspective9
Exhaled breath analysis in interstitial lung disease9
Multidisciplinary care in nonmalignant central airway obstruction9
Infection control in cystic fibrosis: evolving perspectives and challenges8
Interventional pulmonology: reflection on the past, perfecting the present and innovating for the future8
Role of extracorporeal membrane oxygenation and surgical embolectomy in acute pulmonary embolism8
The current understanding and future directions for sputum microbiome profiling in chronic obstructive pulmonary disease8
Epigenetics and aging: relevance for sleep medicine8
Pediatric interventional bronchoscopy: from early limitations to achievable opportunities8
Transbronchial biopsy vs. bronchoalveolar lavage in interstitial lung disease8
The changing landscape of infections in the lung transplant recipient8
Altered pharmacology and toxicology during ageing: implications for lung disease8
Telerehabilitation in pulmonary diseases8
Pulmonary rehabilitation in idiopathic pulmonary fibrosis8
Editorial: ‘What is your occupation?’: historical snippets8
Occupational exposures and sarcoidosis: current understanding and knowledge gaps7
Advancing bacteriophages as a treatment of antibiotic-resistant bacterial pulmonary infections7
Adenotonsillectomy: the good, the bad and the unknown7
Right ventricular assessment in pulmonary hypertension7
Military deployment-related respiratory problems: an update7
Prader–Willi syndrome: an update7
Rigid versus flexible bronchoscopy in interventional pulmonology: perspective from the master clinicians7
Ergonomics in bronchoscopy7
Approach to the hospitalized patient with pulmonary arterial hypertension7
Pulmonary embolism work-up in chronic obstructive pulmonary disease exacerbations: what is the best strategy for clinicians?7
The association of preexisting severe asthma with COVID-19 outcomes7
Telehealth and virtual health monitoring in cystic fibrosis7
Pre-chronic obstructive pulmonary disease: a pathophysiologic process or an opinion term?6
Methamphetamine-associated pulmonary arterial hypertension6
Editorial introductions6
Health inequities in the modulator era6
Artificial intelligence for the optimal management of community-acquired pneumonia6
Pulmonary rehabilitation in a postcoronavirus disease 2019 world: feasibility, challenges, and solutions6
Long-term safety, durability of response, cessation and switching of biologics6
Editorial introductions6
Pulmonary vascular disease in chronic lung diseases: cause or comorbidity?6
Lobar or sublobar resection of peripheral stage I non-small cell lung cancer6
Bronchoscopic lung volume reduction in emphysema: a review6
Advancements in airway stents: a comprehensive update6
Examining the impact of air pollution, climate change, and social determinants of health on asthma and environmental justice6
Updates in the diagnosis and management of chronic thromboembolic disease6
Editorial introductions6
Chronic obstructive pulmonary disease and cardiovascular disease: mechanistic links and implications for practice6
Role of biomarkers in lung nodule evaluation5
Bronchoscopic interventions for chronic bronchitis5
Burden, clinical features, and outcomes of post-tuberculosis chronic obstructive lung diseases5
Pulmonary alveolar proteinosis – current and future therapeutical strategies5
Bacteriophages for bronchiectasis: treatment of the future?5
Editorial introductions5
Editorial: The role of ageing in pulmonary disease5
Recent advances predict a bright future for nebulizers5
Clinical trials in pulmonary sarcoidosis; what is needed, what is happening and what is next?5
Revealing the pathogenic and ageing-related mechanisms of the enigmatic idiopathic pulmonary fibrosis (and chronic obstructive pulmonary disease)5
Whole lung and sequential bronchoscopic lavage for pulmonary alveolar proteinosis5
What is new in mediastinal staging?5
Cyclic alternating patterns and arousals: what is relevant in obstructive sleep apnea? In Memoriam Mario Giovanni Terzano5
Editorial introductions5
Interrelationships between tuberculosis and chronic obstructive pulmonary disease5
Drug-resistant tuberculosis: advances in diagnosis and management5
Editorial introductions4
Anesthetic considerations in interventional pulmonology4
Cryoprobe biopsy versus mechanical biopsies in pulmonary diagnostics4
Use of biologics for the treatment of moderate-to-severe asthma: the age of personalized medicine4
Pulmonary Langerhans cell histiocytosis – an update on pathogenesis and treatment4
Environmental and occupational exposures in interstitial lung disease4
Perioperative management of Obstructive Sleep Apnoea: Present themes and future directions4
Interstitial lung disease following coronavirus disease 20194
Infection control in the bronchoscopy suite: effective reprocessing and disinfection of reusable bronchoscopes4
Recent developments in occupational asthma4
Indwelling pleural catheters for benign pleural effusions: a concise review4
Interstitial lung disease in patients with anti-neutrophil cytoplasm antibody-associated vasculitis: an update on pathogenesis and treatment4
Applications of artificial intelligence in computed tomography imaging for phenotyping pulmonary hypertension4
‘Personalized medicine’: phenotyping pediatric obstructive sleep apnea4
Obstructive sleep apnea in the patient with atrial fibrillation: current knowledge and remaining uncertainties4
Editorial: Endobronchial valve placement for endoscopic lung volume reduction (ELVR): “the start of a new era”4
Endobronchial treatment of severe asthma and severe emphysema with hyperinflation4
Lung infections due to emerging fungal pathogens4
Initiation of home noninvasive ventilation in hypercapnic chronic obstructive pulmonary disease: when, where, and how?4
Risk stratification of pulmonary embolism4
Whole lung lavage: considerations from the anesthesiology perspective4
Vitamin D deficiency in chronic obstructive pulmonary disease3
Editorial introductions3
Editorial introduction3
The controversy over daylight saving time: evidence for and against3
Lung transplantation: practical and important directions of care3
SMART - is it practical in the United States?3
Bedside to bench and back again-translational research in interventional pulmonology3
Sex differences in sleep and sleep-disordered breathing3
Optimal long-term anticoagulation after acute pulmonary embolism: current state of the art and a look into the near future3
Emerging phenotypes of pulmonary hypertension associated with COPD: a field guide3
Management of complicated parapneumonic effusions3
Advances in the epidemiology, clinical features, diagnosis, clinical management and prevention of coronavirus disease 20193
Percutaneous tracheostomy in the ICU: a review of the literature and recent updates3
Pregnancy and fertility in people with cystic fibrosis following lung transplantation3
Pulmonary adverse events following immune checkpoint inhibitors3
The treatment of sarcoidosis: translating the European respiratory guidelines into clinical practice3
Pulmonary hypertension in interstitial lung disease and in chronic obstructive pulmonary disease: different entities?3
COVID-19: vaccines, efficacy and effects on variants3
Epidemiology of advanced cystic fibrosis lung disease in the modulator era3
Asthma guidelines: comparison of the National Heart, Lung, and Blood Institute Expert Panel Report 4 with Global Initiative for Asthma 20213
Predictors and markers of the cardiovascular impact of obstructive sleep apnoea3
Telehealth and its implementation in respiratory sleep medicine3
Progress and challenges in fungal lung disease in cystic fibrosis3
Glymphatic MRI techniques in sleep and neurodegenerative diseases3
0.099257946014404